» Articles » PMID: 23319740

A Citrullinated Fibrinogen-specific T Cell Line Enhances Autoimmune Arthritis in a Mouse Model of Rheumatoid Arthritis

Overview
Journal J Immunol
Date 2013 Jan 16
PMID 23319740
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Citrullinated proteins, derived from the conversion of peptidyl-arginine to peptidyl-citrulline, are present in the joints of patients with rheumatoid arthritis (RA), who also uniquely produce high levels of anti-citrullinated protein Abs. Citrullinated fibrinogen (CF) is abundant in rheumatoid synovial tissue, and anti-citrullinated protein Ab-positive RA patients exhibit circulating immune complexes containing CF. Thus, CF is a potential major target of pathogenic autoimmunity in RA. T cells are believed to be involved in this process by initiating, controlling, and driving Ag-specific immune responses in RA. In this study, we isolated a CD4 T cell line specific for CF that produces inflammatory cytokines. When transferred into mice with collagen-induced arthritis (CIA), this T cell line specifically enhanced the severity of autoimmune arthritis. Additionally, pathogenic IgG2a autoantibody levels to mouse type II collagen were increased in mice that received the T cells in CIA, and levels of these T cells were increased in the synovium, suggesting the T cells may have had systemic effects on the B cell response as well as local effects on the inflammatory environment. This work demonstrates that CD4 T cells specific for CF can amplify disease severity after onset of CIA.

Citing Articles

Antigen-specific T-cell frequency and phenotype mirrors disease activity in DRB1*04:04+ rheumatoid arthritis patients.

Rims C, Uchtenhagen H, Brooks K, Ng B, Posso S, Carlin J Clin Exp Immunol. 2024; 219(1).

PMID: 39492692 PMC: 11754868. DOI: 10.1093/cei/uxae102.


Making inroads to precision medicine for the treatment of autoimmune diseases: Harnessing genomic studies to better diagnose and treat complex disorders.

Baglaenko Y, Wagner C, Bhoj V, Brodin P, Gershwin M, Graham D Camb Prism Precis Med. 2024; 1:e25.

PMID: 38550937 PMC: 10953750. DOI: 10.1017/pcm.2023.14.


How to Model Rheumatoid Arthritis in Animals: From Rodents to Non-Human Primates.

Zhao T, Xie Z, Xi Y, Liu L, Li Z, Qin D Front Immunol. 2022; 13:887460.

PMID: 35693791 PMC: 9174425. DOI: 10.3389/fimmu.2022.887460.


Impact of Posttranslational Modification in Pathogenesis of Rheumatoid Arthritis: Focusing on Citrullination, Carbamylation, and Acetylation.

Kwon E, Ju J Int J Mol Sci. 2021; 22(19).

PMID: 34638916 PMC: 8508717. DOI: 10.3390/ijms221910576.


Follicular helper T cells: potential therapeutic targets in rheumatoid arthritis.

Lu J, Wu J, Xia X, Peng H, Wang S Cell Mol Life Sci. 2021; 78(12):5095-5106.

PMID: 33880615 PMC: 11073436. DOI: 10.1007/s00018-021-03839-1.


References
1.
Krueger G, Langley R, Leonardi C, Yeilding N, Guzzo C, Wang Y . A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N Engl J Med. 2007; 356(6):580-92. DOI: 10.1056/NEJMoa062382. View

2.
Gregersen P, Silver J, Winchester R . The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 1987; 30(11):1205-13. DOI: 10.1002/art.1780301102. View

3.
Kannan K, Ortmann R, Kimpel D . Animal models of rheumatoid arthritis and their relevance to human disease. Pathophysiology. 2005; 12(3):167-81. DOI: 10.1016/j.pathophys.2005.07.011. View

4.
Zhao Y, Tian X, Li Z . Prevalence and clinical significance of antibodies to citrullinated fibrinogen (ACF) in Chinese patients with rheumatoid arthritis. Clin Rheumatol. 2007; 26(9):1505-12. DOI: 10.1007/s10067-007-0544-y. View

5.
Fox D, Gizinski A, Morgan R, Lundy S . Cell-cell interactions in rheumatoid arthritis synovium. Rheum Dis Clin North Am. 2010; 36(2):311-23. PMC: 2879397. DOI: 10.1016/j.rdc.2010.02.004. View